Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer.
Redman JM, Friedman J, Robbins Y, Sievers C, Yang X, Lassoued W, Sinkoe A, Papanicolau-Sengos A, Lee CC, Marte JL, Turkbey E, Mydlarz W, Joshi A, London NR Jr, Pierce M, Taylor R, Hong S, Nguyen A, Soon-Shiong P, Schlom J, Gulley JL, Allen CT.
Redman JM, et al.
J Clin Invest. 2022 Sep 15;132(18):e161400. doi: 10.1172/JCI161400.
J Clin Invest. 2022.
PMID: 35727629
Free PMC article.
Clinical Trial.